missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human VEGF 165 Protein
Click to view available options
Cantidad:
1 mg
10 μg
50 μg
500 μg
Formulación:
Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with trehalose.
Tamaño de la unidad:
1 miligramo
10 microgramos
50 microgramos
500 microgramos
Descripción
Measured in a cell proliferation assay using HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci. USA 87:1323. The ED50 for this effect is 1-6 ng/mL. The specific activity of recombinant human VEGF165 is approximately 1.7 x 103 U/μg, which is calibrated against recombinant human VEGF165 WHO Standard (NIBSC code: 02/286). Specific activity is for reference purposes only and is not routinely tested.

Especificaciones
Especificaciones
Formulación | Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with trehalose. |
ID de gen (Entrez) | 7422 |
Peso molecular | observed_molecular_weight: 20-22 kDa, under reducing conditions. 39-42 kDa, under non-reducing conditions. |
Nombre | VEGF 165 |
Cantidad | 1 mg |
Fuente | Spodoptera frugiperda,Sf 21 (baculovirus)-derived human VEGF protein Ala27-Arg191 |
Requisitos de almacenamiento | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
Forma estructural | Disulfide-linked homodimer |
Conjugado | Unconjugated |
Recombinante | Recombinant |
Mostrar más |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
R&D Systems™ Recombinant Human VEGF 165 Protein >
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido